Infinity Pharmaceuticals (NASDAQ:INFI) stock is rocketing higher on Tuesday morning despite a lack of news from the biopharmaceutical company. Investors seeking out news concerning shares of INFI ...
Infinity Pharmaceuticals (INFI) has been on a downward spiral lately with significant selling pressure. After declining 44.4% over the past four weeks, the stock looks well positioned for a trend ...
If you want to know who really controls Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), then you'll have to look at the makeup of its share registry. Insiders often own a large chunk of younger, smaller ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback